Foster Dykema Cabot & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $20.6M | Buy |
59,357
+42
| +0.1% | +$14.6K | 2.5% | 13 |
|
|
2023
Q2 | $20.9M | Buy |
59,315
+92
| +0.2% | +$32.4K | 2.46% | 14 |
|
|
2023
Q1 | $18.7M | Buy |
59,223
+871
| +1% | +$274K | 2.4% | 16 |
|
|
2022
Q4 | $16.9M | Buy |
58,352
+14,461
| +33% | +$4.18M | 2.36% | 20 |
|
|
2022
Q3 | $12.7M | Buy |
+43,891
| New | +$12.7M | 1.6% | 18 |
|
|
2021
Q3 | – | Sell |
-1,086
| Closed | -$219K | – | 101 |
|
|
2021
Q2 | $219K | Hold |
1,086
| – | – | 0.03% | 88 |
|
|
2021
Q1 | $233K | Hold |
1,086
| – | – | 0.03% | 84 |
|
|
2020
Q4 | $257K | Buy |
+1,086
| New | +$257K | 0.04% | 85 |
|